Shree TirupatiBa (BALAJEE)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 19.82% shows the business is still expanding.
• ROCE of 13.21% indicates decent efficiency in capital employed.
• Debt/Equity of 0.63 is moderate, avoiding excessive leverage risk.
• Promoter holding of 65.42% aligns management interests with minority shareholders.
• P/B of 1.17 near book value offers some asset downside support.

Concerns

• Profit growth collapsed by 98.04%, with latest quarterly net profit of only ₹1 crore on ₹171 crore sales.
• ROE of just 4.21% signals weak shareholder returns.
• Piotroski F-Score of 4/9 points to deteriorating financial health.
• P/E of 17.20 on near-zero earnings is not cheap; no dividend yield either.

AI Analysis

Reading Shree TirupatiBa, I see a packaging company selling at ₹32.74 with a market cap of ₹224 crore. The first thing that stops me is the earnings record: profit growth is down 98%, and the latest quarter delivered only ₹1 crore net profit on ₹171 crore of sales. That is a razor-thin margin, and it tells me this business has little pricing power. A 4.21% return on equity is far below what I would accept from a quality compounder; Ben Graham would call this near-speculation. Sales growth of 19.82% sounds nice, but if those sales do not convert into profits, growth is just revenue for revenue's sake. The balance sheet is not alarming — debt/equity of 0.63 and book value of ₹28.08 mean the stock trades at 1.17 times book, offering some asset support. ROCE at 13.21% is respectable, so capital employed is earning something. But the Piotroski score of 4/9 warns of deteriorating financial health, and there is no dividend to compensate while I wait. I cannot rely on the PEG of 0.87 because it compares price to sales growth, while reported earnings have collapsed; that is an unreliable shortcut. Promoters hold 65.42%, which aligns interests, but even high ownership cannot rescue a poor margin. At ₹32.74, near the lower end of its 52-week range, the market is disappointed. This is a turnaround candidate, not a stalwart. I would need to see at least a few quarters of improving net margins and a believable path to normalized earnings before I commit capital. Price alone is not value.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer